Oxford Sciences Innovation

Our mission is to enable Oxford’s scientists and entrepreneurs to build the companies that solve the world’s most important problems.

Oxford Sciences Innovation is a leading science and technology business. We ensure Oxford’s world-leading science moves out of the laboratory and onto the global stage. In partnership with the University of Oxford, OSI creates fundamental technology companies, built on science. We match scientists with experienced entrepreneurs and patient capital to turn idea to impact, discovery to company.

Updates

Oxford Sciences Innovation @OSI_Updates·

Big welcome today to John McHutchison who joins the board of @EvOx_Ltd as OSI's representative. John is a highly experienced life science executive and will be invaluable as @EvOx_Ltd advance their exosome therapeutics into the clinic. Read more: https://www.evoxtherapeutics.com/News/Jan-2021/John-McHutchison-Joins-Evox-Board

Reply on Twitter 1351113649927180292 Retweet on Twitter 1351113649927180292 Like on Twitter 13511136499271802926 Twitter 1351113649927180292

Retweet on Twitter Oxford Sciences Innovation Retweeted

Perspectum @PerspectumGroup·

14 Jan

We are proud to announce the world’s first integrated imaging service for Long Covid has been approved by the UK’s MHRA.

#longcovid #coverscan #perspectum #medtech #healthcare

Read more: https://perspectum.com/news/world-s-first-integrated-imaging-service-for-long-covid-approved-by-uk-s-mhra

Reply on Twitter 1349755052861378561 Retweet on Twitter 134975505286137856112 Like on Twitter 134975505286137856122 Twitter 1349755052861378561

Oxford Sciences Innovation @OSI_Updates·

15 Jan

Approval from @MHRAgovuk for @PerspectumGroup’s CoverScan MD for #LongCovid 👏

Congratulations Perspectum and thank you for bringing us more good news in the fight against #COVIDー19!

Read more: https://bit.ly/3srlyrQ

Reply on Twitter 1350019534850240517 Retweet on Twitter 13500195348502405173 Like on Twitter 135001953485024051711 Twitter 1350019534850240517

John McHutchison joins the board of Evox Therapeutics

Perspectum’s CoverScan MD approved by the UK’s MHRA – the world’s first integrated imaging service capable of mapping the impact of COVID-19 on the body

Ex-Centrica and BP boss Iain Conn joins Oxford Flow board

OQC lab takes delivery of first Proteox worldwide – a significant milestone to building a quantum-powered future

OQC state-of-the-art quantum laboratory opens

Theolytics raises $6.8 million Series A round co-led by Epidarex Capital and Taiho Ventures to advance viral cancer therapies

Ultromics’ first-of-a-kind AI solution to help clinicians diagnose coronary artery disease from echiocardiograms in a matter of minutes approved by the FDA

Bodle Technologies Secures Series A Funding Extension

Perspectum issued CPT® Codes for LiverMultiScan® by the American Medical Association to help Drs diagnose and treat liver disease

Clean nuclear: Oxford start-up 10 years ahead of government targets in race to build fusion plant

LifeArc co-leads £6 million funding in DJS Antibodies

MERRY CHRISTMAS FROM ALL THE TEAM AT OSI